{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:56:35Z","timestamp":1775814995575,"version":"3.50.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Progranulin (PGRN), endothelial cell-specific molecule-1, clusterin (CLU), and human epididymis protein 4 (HE-4) are novel proteins reported to have diagnostic and prognostic potential in lung cancer. Here, we aimed to identify the markers with high sensitivity and specificity in distinguishing malignant pleural fluids from other pleural fluids.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This prospective, descriptive study was conducted at a medical faculty hospital between 2016 and 2019. The study population consisted of 90 patients &lt;18 years of age with pleural effusion (PE). Levels of pleural fluids of PGRN, endothelial cell-specific molecule-1, CLU, and HE-4 were measured with enzyme-linked immunosorbent assay kits under the manufacturer\u2019s manual.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 90 patients, 54 were men, and 36 were women (mean age 65\u2005\u00b1\u200516 years). Of pleural fluids investigated, 23 (25%) and 67 (74%) were transudates and exudates, respectively. Of exudates, while 27 (40%) and 19 (28%) were parapneumonic PE and tuberculous PE, respectively, 20 (29%) were malignant pleural effusion (MPE). Levels of all biomarkers in exudate fluids were found significantly higher than those of transudate fluids. CLU, HE-4, and PGRN levels in MPE were also found significantly higher than benign fluids (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Cutoff values were achieved by receiver operating characteristics analysis for CLU, HE-4, and PGRN to distinguish between malignant and benign groups. For diagnosis of MPE, the sensitivity and specificity values were found as 0.66 and 0.67 for a cutoff value of CLU of 18.29\u2009mg\/L (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.00), as 0.76 and 0.76 for a cutoff value of HE-4 of 9.33\u2009mg\/L (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.00), and as 0.66 and 0.67 for a cutoff value of PGRN of 105.91\u2009mg\/L (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>HE-4 having high sensitivity and specificity can be a potential diagnostic marker in distinguishing between malignant and benign effusions, and these findings can constitute a basis for future research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032471","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T13:01:19Z","timestamp":1672405279000},"page":"e32471","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["The investigation of levels of endothelial cell-specific molecule, progranuline, clusterin, and human epididymis protein 4 in the differential diagnosis of malignant pleural effusions"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-0217","authenticated-orcid":false,"given":"Soner","family":"Demirbas","sequence":"first","affiliation":[{"name":"Department of Chest Diseases, Meram Faculty of Medicine, Necmetin Erbakan University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma H\u00fcmeyra","family":"Yerlikaya","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebnem","family":"Yosunkaya","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Meram Faculty of Medicine, Necmetin Erbakan University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ummugulsum","family":"Can","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Konya Training and Research Hospital, Konya, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korkmaz","family":"Celalettin","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Meram Faculty of Medicine, Necmetin Erbakan University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"1055","article-title":"Pleural effusions.","volume":"95","author":"Light","year":"2011","journal-title":"Med Clin"},{"issue":"Suppl 2","key":"R2-20250504","doi-asserted-by":"crossref","first-page":"ii4","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: British thoracic society pleural disease guideline 2010.","volume":"65","author":"Hooper","year":"2010","journal-title":"Thorax"},{"issue":"Suppl 2","key":"R3-20250504","doi-asserted-by":"crossref","first-page":"ii8","DOI":"10.1136\/thx.58.suppl_2.ii8","article-title":"BTS guidelines for the investigation of a unilateral pleural effusion in adults.","volume":"58","author":"Maskell","year":"2003","journal-title":"Thorax"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000338169","article-title":"Pleural effusion in lung cancer: more questions than answers.","volume":"83","author":"Froudarakis","year":"2012","journal-title":"Respiration"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1378\/chest.08-2968","article-title":"Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.","volume":"136","author":"William","year":"2009","journal-title":"Chest"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions.","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology (Carlton, Vic)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/thx.34.1.106","article-title":"Pleural effusion: laboratory tests in 300 cases.","volume":"34","author":"Hirsch","year":"1979","journal-title":"Thorax"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0025-6196(12)60212-2","article-title":"Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.","volume":"60","author":"Prakash","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1165\/rcmb.2005-0130OC","article-title":"Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.","volume":"34","author":"Stathopoulos","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","article-title":"Malignant pleural effusion: tumor-host interactions unleashed.","volume":"186","author":"Stathopoulos","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1074\/jbc.271.34.20458","article-title":"ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines.","volume":"271","author":"Lassalle","year":"1996","journal-title":"J Biol Chem"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer.","volume":"415","author":"van \u2018t Veer","year":"2002","journal-title":"Nature"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-3-31","article-title":"Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data.","volume":"3","author":"Lenburg","year":"2003","journal-title":"BMC cancer"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-03-2361","article-title":"Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.","volume":"64","author":"Amatschek","year":"2004","journal-title":"Cancer Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/rccm.200401-066OC","article-title":"Molecular signatures in biopsy specimens of lung cancer.","volume":"170","author":"Borczuk","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20250504","first-page":"3222","article-title":"Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo.","volume":"59","author":"He","year":"1999","journal-title":"Cancer Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0065-230X(09)05007-6","article-title":"Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.","volume":"105","author":"Sala","year":"2009","journal-title":"Adv Cancer Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1080\/10715760600902310","article-title":"Regulation of clusterin\/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.","volume":"40","author":"Trougakos","year":"2006","journal-title":"Free Radic Res"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2014.06.026","article-title":"Apolipoprotein J, a glucose-upregulated molecular chaperone, stabilizes core and NS5A to promote infectious hepatitis C virus virion production.","volume":"61","author":"Lin","year":"2014","journal-title":"J Hepatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/cas.12434","article-title":"Immunophenotypic features of metastatic lymph node tumors to predict recurrence in N2 lung squamous cell carcinoma.","volume":"105","author":"Matsuwaki","year":"2014","journal-title":"Cancer Sci"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cca.2017.05.007","article-title":"HE4 expression in lung cancer, a meta-analysis.","volume":"470","author":"Zhong","year":"2017","journal-title":"Clin Chim Acta"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.21037\/jtd.2019.06.72","article-title":"Diagnostic accuracy of human epididymis secretory protein 4 for lung cancer: a systematic review and meta-analysis.","volume":"11","author":"Yan","year":"2019","journal-title":"J Thorac Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccm.2012.11.002","article-title":"Pleural fluid biomarkers: beyond the Light criteria.","volume":"34","author":"Porcel","year":"2013","journal-title":"Clin Chest Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1073\/pnas.241500798","article-title":"Diversity of gene expression in adenocarcinoma of the lung.","volume":"98","author":"Garber","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/CBM-190840","article-title":"Diagnostic value of human epididymis protein 4 in malignant pleural effusion in lung cancer.","volume":"26","author":"Lv","year":"2019","journal-title":"Cancer Biomark"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s13277-012-0427-y","article-title":"Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion.","volume":"33","author":"Elsammak","year":"2012","journal-title":"Tumour Biol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3343\/alm.2017.37.6.526","article-title":"Clinical usefulness of human epididymis protein 4 in lung cancer.","volume":"37","author":"Choi","year":"2017","journal-title":"Ann Lab Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues.","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung.","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir Res"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13277-010-0118-5","article-title":"Prognostic significance of HE4 expression in pulmonary adenocarcinoma.","volume":"32","author":"Yamashita","year":"2011","journal-title":"Tumour Biol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer.","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumour Biol"},{"key":"R34-20250504","first-page":"6084","article-title":"Overexpression of endocan induces tumor formation.","volume":"63","author":"Scherpereel","year":"2003","journal-title":"Cancer Res"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000025758","article-title":"Characterization of the secreted form of endothelial-cell-specific molecule 1 by specific monoclonal antibodies.","volume":"37","author":"Bechard","year":"2000","journal-title":"J Vasc Res"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"R1602","DOI":"10.1152\/ajpregu.00616.2005","article-title":"Regulation of progranulin expression in myeloid cells.","volume":"291","author":"Ong","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"107964107964","DOI":"10.18632\/oncotarget.22438","article-title":"Calsyntenin-1, clusterin and neutrophil gelatinase-associated lipocalin are candidate serological biomarkers for lung adenocarcinoma.","volume":"8","author":"Chu","year":"2017","journal-title":"Oncotarget"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"e0161150","DOI":"10.1371\/journal.pone.0161150","article-title":"Prognostic role of secretory clusterin in multiple human malignant neoplasms: a meta-analysis of 26 immunohistochemistry studies.","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2147\/CMAR.S196273","article-title":"The role of Clusterin in cancer metastasis.","volume":"11","author":"Peng","year":"2019","journal-title":"Cancer Manag Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:25:22Z","timestamp":1746332722000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":39,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032471","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}